摘要
优立新与头孢噻肟随机对照治疗呼吸道和泌尿道感染40例,临床有效率各为100%和95%(P>0.05),细菌阴转率各为94,1%和100%(P>0.05)。无显著性差异。优立新共治疗30例,临床有效率和细菌阴转率分别为100%和96%。两药副反应均轻微。无因副反应而停药。在优立新治疗病例中,有2例出现皮疹。另2例为肝功能ALT和AST暂时性轻度增高。
50 hospitalized patients were treated for acute respiratory tract, urinary tract, or other infections. In the randomized trial, there were 20 cases in either Unasyn (sulbactam/ampicillin)or Cefotaxime treatment group. The clinical efficacy rates were 100% for Unasyn and 95% for Cefotaxime(P>0.05),and the eradication rates of pathogens were 94.1% and 100% , respectively (P>0.05). Unasyn was administered to a total of 30 patients. Tbe clinical efficacy was 100% and the eradication rate of pathogens was 96% .No serious side effects of both drugs Were observed.
出处
《重庆医科大学学报》
CAS
CSCD
1997年第2期105-108,共4页
Journal of Chongqing Medical University
关键词
优立新
头孢噻肟
细菌性感染
Unasyn: Sulbactam
Ampicillin
Cefotaxime
Clinical efficacy